These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 28556501)

  • 1. A three-gene signature from protein-protein interaction network of LOXL2- and actin-related proteins for esophageal squamous cell carcinoma prognosis.
    Zhan XH; Jiao JW; Zhang HF; Li CQ; Zhao JM; Liao LD; Wu JY; Wu BL; Wu ZY; Wang SH; Du ZP; Shen JH; Zou HY; Neufeld G; Xu LY; Li EM
    Cancer Med; 2017 Jul; 6(7):1707-1719. PubMed ID: 28556501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein-coding genes combined with long non-coding RNAs predict prognosis in esophageal squamous cell carcinoma patients as a novel clinical multi-dimensional signature.
    Guo JC; Li CQ; Wang QY; Zhao JM; Ding JY; Li EM; Xu LY
    Mol Biosyst; 2016 Oct; 12(11):3467-3477. PubMed ID: 27714034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a nomogram based on long non-coding RNA to improve prognosis prediction of esophageal squamous cell carcinoma.
    Li W; Liu J; Zhao H
    Aging (Albany NY); 2020 Jan; 12(2):1512-1526. PubMed ID: 31978896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploration of potential roles of a new LOXL2 splicing variant using network knowledge in esophageal squamous cell carcinoma.
    Wu BL; Lv GQ; Zou HY; Du ZP; Wu JY; Zhang PX; Xu LY; Li EM
    ScientificWorldJournal; 2014; 2014():431792. PubMed ID: 25254241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of LOXL4 expression and features of LOXL4-associated protein-protein interaction network in esophageal squamous cell carcinoma.
    Xie W; Huang P; Wu B; Chen S; Huang Z; Wang J; Sun H; Wu J; Xie L; Cheng Y; Xie W; Xu L; Chen LQ; Li E; Zou H
    Amino Acids; 2019 May; 51(5):813-828. PubMed ID: 30900087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SMYD3 stimulates EZR and LOXL2 transcription to enhance proliferation, migration, and invasion in esophageal squamous cell carcinoma.
    Zhu Y; Zhu MX; Zhang XD; Xu XE; Wu ZY; Liao LD; Li LY; Xie YM; Wu JY; Zou HY; Xie JJ; Li EM; Xu LY
    Hum Pathol; 2016 Jun; 52():153-63. PubMed ID: 26980013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein-protein interaction network analyses for elucidating the roles of LOXL2-delta72 in esophageal squamous cell carcinoma.
    Wu BL; Zou HY; Lv GQ; Du ZP; Wu JY; Zhang PX; Xu LY; Li EM
    Asian Pac J Cancer Prev; 2014; 15(5):2345-51. PubMed ID: 24716982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High MLL2 expression predicts poor prognosis and promotes tumor progression by inducing EMT in esophageal squamous cell carcinoma.
    Abudureheman A; Ainiwaer J; Hou Z; Niyaz M; Turghun A; Hasim A; Zhang H; Lu X; Sheyhidin I
    J Cancer Res Clin Oncol; 2018 Jun; 144(6):1025-1035. PubMed ID: 29532228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma.
    Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J
    Front Immunol; 2021; 12():669750. PubMed ID: 34054840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a novel lysyl oxidase-like 2 alternative splicing isoform, LOXL2 Δe13, in esophageal squamous cell carcinoma.
    Lv GQ; Zou HY; Liao LD; Cao HH; Zeng FM; Wu BL; Xie JJ; Fang WK; Xu LY; Li EM
    Biochem Cell Biol; 2014 Oct; 92(5):379-89. PubMed ID: 25275797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioinformatics Analysis Reveals a Novel Prognostic Model for Esophageal Squamous Cell Carcinoma.
    Yang H; Chen Y; Huang X; Gu Y; Chen Z; Mao W
    Int J Med Sci; 2024; 21(7):1213-1226. PubMed ID: 38818465
    [No Abstract]   [Full Text] [Related]  

  • 12. Cripto-1 acts as a functional marker of cancer stem-like cells and predicts prognosis of the patients in esophageal squamous cell carcinoma.
    Liu Q; Cui X; Yu X; Bian BS; Qian F; Hu XG; Ji CD; Yang L; Ren Y; Cui W; Zhang X; Zhang P; Wang JM; Cui YH; Bian XW
    Mol Cancer; 2017 Apr; 16(1):81. PubMed ID: 28431580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TRPV6 plays a new role in predicting survival of patients with esophageal squamous cell carcinoma.
    Zhang SS; Xie X; Wen J; Luo KJ; Liu QW; Yang H; Hu Y; Fu JH
    Diagn Pathol; 2016 Jan; 11():14. PubMed ID: 26818094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 10‑microRNA prognosis scoring system in esophageal squamous cell carcinoma constructed using bioinformatic methods.
    Sun Q; Zong L; Zhang H; Deng Y; Zhang C; Zhang L
    Mol Med Rep; 2018 Apr; 17(4):5222-5228. PubMed ID: 29393486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An esophageal squamous cell carcinoma classification system that reveals potential targets for therapy.
    Xiong T; Wang M; Zhao J; Liu Q; Yang C; Luo W; Li X; Yang H; Kristiansen K; Roy B; Zhou Y
    Oncotarget; 2017 Jul; 8(30):49851-49860. PubMed ID: 28591712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A six-microRNA risk score model predicts prognosis in esophageal squamous cell carcinoma.
    Mao Y; Fu Z; Zhang Y; Dong L; Zhang Y; Zhang Q; Li X; Wang C
    J Cell Physiol; 2019 May; 234(5):6810-6819. PubMed ID: 30387125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel fatty acid metabolism-related signature identifies MUC4 as a novel therapy target for esophageal squamous cell carcinoma.
    Li S; Liu Z; Chen Q; Chen Y; Ji S
    Sci Rep; 2024 May; 14(1):12476. PubMed ID: 38816411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A three-lncRNA signature predicts overall survival and disease-free survival in patients with esophageal squamous cell carcinoma.
    Huang GW; Xue YJ; Wu ZY; Xu XE; Wu JY; Cao HH; Zhu Y; He JZ; Li CQ; Li EM; Xu LY
    BMC Cancer; 2018 Feb; 18(1):147. PubMed ID: 29409459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulated expression of PTK6 is correlated with poor survival in esophageal squamous cell carcinoma.
    Chen YF; Ma G; Cao X; Huang ZL; Zeng MS; Wen ZS
    Med Oncol; 2014 Dec; 31(12):317. PubMed ID: 25377660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein-coding genes combined with long noncoding RNA as a novel transcriptome molecular staging model to predict the survival of patients with esophageal squamous cell carcinoma.
    Guo JC; Wu Y; Chen Y; Pan F; Wu ZY; Zhang JS; Wu JY; Xu XE; Zhao JM; Li EM; Zhao Y; Xu LY
    Cancer Commun (Lond); 2018 Apr; 38(1):4. PubMed ID: 29784063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.